Provided by Tiger Fintech (Singapore) Pte. Ltd.

Imunon, Inc.

0.8876
-0.0342-3.71%
Pre-market: 0.90990.0223+2.51%08:04 EDT
Volume:954.10K
Turnover:876.74K
Market Cap:18.91M
PE:-0.64
High:0.9560
Open:0.9200
Low:0.8500
Close:0.9218
Loading ...

Imunon presents data from its Phase 2 OVATION 2 study of IMNN-001

TIPRANKS
·
18 Jun

Imunon Inc. Files Initial Statement of Beneficial Ownership for CFO Kimberly Bragg

Reuters
·
18 Jun

Imunon announces abstract on Phase 1 proof-of-concept trial of IMNN-101

TIPRANKS
·
17 Jun

Imunon Announces Placcine® DNA Vaccine Technology Abstract Selected for Oral Presentation at 10TH International Conference on Vaccines Research & Development™

THOMSON REUTERS
·
17 Jun

BRIEF-Imunon - Terminates CFO David Gaiero's Service Agreement

Reuters
·
14 Jun

Imunon Inc - Appoints Kimberly Graper as Interim CFO - SEC Filing

THOMSON REUTERS
·
14 Jun

Imunon - Terminates CFO David Gaiero's Service Agreement - SEC Filing

THOMSON REUTERS
·
14 Jun

Imunon Inc. Appoints Kimberly Graper as Interim Chief Financial Officer Following Termination of Consulting Agreement with David Gaiero

Reuters
·
14 Jun

Imunon Inc. Requests Hearing to Appeal Nasdaq Delisting as Stock Regains Compliance with Bid Price Requirement

Reuters
·
10 Jun

Imunon Inc. Presents Updated Survival Analysis from OVATION-2 Trial on Safety and Efficacy of IMNN-001 in Advanced EOC Patients

Reuters
·
03 Jun

Imunon announces data from Phase 2 OVATION 2 study on IMNN-001

TIPRANKS
·
03 Jun

Imunon Announces Data Presented at Asco Reinforces Unprecedented Overall Survival in Ovarian Cancer Phase 2 Study

THOMSON REUTERS
·
03 Jun

Imunon files to sell 22.03M shares of common stock for holders

TIPRANKS
·
31 May

Imunon Inc. Faces Nasdaq Delisting After Failing to Meet Minimum Bid Price Requirement

Reuters
·
31 May

Imunon Closes Private Placement of Shares, Warrants to Raise Up to $9.75 Million

MT Newswires Live
·
29 May

Imunon Closes up to $9.75 Million Private Placement Priced at-the-Market Under Nasdaq Rules

THOMSON REUTERS
·
29 May

Imunon Invited to Present Translational Data in Supporting Remarkable Phase 2 Ovarian Cancer Survival Results at Esmo Gynaecological Cancers Congress 2025

THOMSON REUTERS
·
27 May

Imunon announces up to $9.75M private placement priced at-the-market

TIPRANKS
·
26 May

Imunon Announces up to $9.75 Million Private Placement Priced at-the-Market Under Nasdaq Rules

THOMSON REUTERS
·
24 May

IMUNON Announces Up To $9.75 Million Private Placement Priced At-The-Market Under Nasdaq Rules

GlobeNewswire
·
24 May